celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxórúbicín hýdróklóríð - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - Æxlishemjandi lyf - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
metylfenidat actavis forðatafla 18 mg
actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 18 mg
microgyn tafla
bayer ab* - levonorgestrelum inn; ethinylestradiolum inn - tafla
methylphenidate sandoz forðatafla 27 mg
sandoz a/s - methylphenidatum hýdróklóríð - forðatafla - 27 mg
ibandronic acid wh stungulyf, lausn 3 mg
williams & halls ehf - acidum ibandronicum mónónatríum - stungulyf, lausn - 3 mg
medikinet tafla 10 mg
medice arzneimittel pütter gmbh & co. kg* - methylphenidatum hýdróklóríð - tafla - 10 mg
medikinet tafla 20 mg
medice arzneimittel pütter gmbh & co. kg* - methylphenidatum hýdróklóríð - tafla - 20 mg
medikinet tafla 5 mg
medice arzneimittel pütter gmbh & co. kg* - methylphenidatum hýdróklóríð - tafla - 5 mg
mercilon tafla 150 míkróg/20 míkróg
n.v. organon* - desogestrelum inn; ethinylestradiolum inn - tafla - 150 míkróg/20 míkróg
metylfenidat actavis forðatafla 27 mg
actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 27 mg